glp-1 nausea lawsuit in michigan Ozempic & Gastroparesis Ozempic and Hemophilia: Is It

Methods Retrospective study utilizing data from a federated research network (TriNetX)

In terms of switching, 22.9% of the GLP-1 receptor agonist users and 2.1% of the SGLT2 inhibitor users switched between drugs within the same drug class

Learn how maintaining the right temperature ensures drug efficacy and patient safety.

We Aim to Provide The Best Experience For Everyone

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.

Group one included patients with moderate PAD who were started on GLP-1 RAs, and group two included patients with moderate PAD who were not started on GLP-1 RAs. At one year, patients with moderate PAD who were started on GLP-1 RAs had fewer major adverse limb events (MALE) (0.8% vs 1.5%), major adverse cardiac events (MACE) (25.4% vs 29.3%), and decreased risk of hospitalizations (17.9 vs 26.8%)